Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Saroja Pharma Ind

₹47 0 | 0%

Market Cap ₹19 Cr.

Stock P/E

P/B 1.3

Current Price ₹47

Book Value ₹ 35.3

Face Value 10

52W High ₹82.9

Dividend Yield 0%

52W Low ₹ 35

Saroja Pharma Ind Research see more...

Overview Inc. Year: 2019Industry: Pharmaceuticals & Drugs

Saroja Pharma Ind Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Saroja Pharma Ind Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Saroja Pharma Ind Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 37 56 50
Other Income 0 0 0
Total Income 37 56 50
Total Expenditure 35 54 47
Operating Profit 1 2 3
Interest 0 1 1
Depreciation 0 0 0
Exceptional Income / Expenses 0 0 0
Profit Before Tax 1 2 1
Provision for Tax 0 0 0
Profit After Tax 1 1 1
Adjustments 0 0 0
Profit After Adjustments 1 1 1
Adjusted Earnings Per Share 56.3 3.9 3.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -11% 0% 0% 0%
Operating Profit CAGR 50% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 23% 49% 49% 49%
ROCE Average 22% 30% 30% 30%

Saroja Pharma Ind Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 1 4 5
Minority's Interest 0 0 0
Borrowings 1 2 3
Other Non-Current Liabilities 0 0 0
Total Current Liabilities 6 10 13
Total Liabilities 8 16 21
Fixed Assets 0 0 2
Other Non-Current Assets 0 0 3
Total Current Assets 8 15 16
Total Assets 8 16 21

Saroja Pharma Ind Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0
Cash Flow from Operating Activities -1 -4 2
Cash Flow from Investing Activities -0 -0 -5
Cash Flow from Financing Activities 1 4 3
Net Cash Inflow / Outflow -0 0 0
Closing Cash & Cash Equivalent 0 0 0

Saroja Pharma Ind Ratios

# Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 56.25 3.88 3.61
CEPS(Rs) 57.98 4.04 3.84
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 71.99 13.72 17.33
Core EBITDA Margin(%) 3.56 3.78 5.42
EBIT Margin(%) 3.73 4.28 5.6
Pre Tax Margin(%) 2.82 2.84 2.97
PAT Margin (%) 1.99 2.05 2.11
Cash Profit Margin (%) 2.06 2.13 2.25
ROA(%) 8.89 9.61 5.76
ROE(%) 78.14 45.95 23.28
ROCE(%) 34.59 33.73 22.1
Receivable days 71.92 69.56 91.22
Inventory Days 6.53 3.68 15.75
Payable days 47.31 35.58 45.99
PER(x) 0 0 0
Price/Book(x) 0 0 0
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.08 0.11 0.25
EV/Core EBITDA(x) 2.18 2.51 4.43
Net Sales Growth(%) 0 51.75 -9.78
EBIT Growth(%) 0 74.15 18.05
PAT Growth(%) 0 55.9 -6.97
EPS Growth(%) 0 -93.1 -6.98
Debt/Equity(x) 3.22 1.52 2
Current Ratio(x) 1.38 1.54 1.2
Quick Ratio(x) 1.27 1.49 0.91
Interest Cover(x) 4.12 2.97 2.13
Total Debt/Mcap(x) 0 0 0

Saroja Pharma Ind Shareholding Pattern

# Sep 2023 Mar 2024
Promoter 73.02 73.02
FII 0 0
DII 0 0
Public 26.98 26.98
Others 0 0
Total 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 49%

Cons

  • Debtor days have increased from 35.58 to 45.99days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Saroja Pharma Ind News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....